Articles Archives - QualityStocks

WednesdayApr 29, 2026 10:30 am

American Fusion(TM) Inc. (AMFN) Targets Government and Defense Channels to Accelerate Commercialization

American Fusion(TM) has appointed a government procurement advisor to expand access to non-dilutive funding channels, prioritizing defense, DOE, and international programs as early commercialization pathways. The company’s Texatron(TM) platform is being positioned for modular, infrastructure-grade applications, with government alignment reflecting a wider trend in fusion toward staged, program-based development. Institutional contracts may offer structured revenue opportunities before full-scale deployment. Engagement with NATO-linked and European programs signals a broader international strategy. American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies recently announced it has engaged Samuel Reid as Government Strategy and Procurement Advisor, a step aimed at aligning its…

WednesdayApr 29, 2026 9:45 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Advances Murdock Mountain Drill Program as Fertilizer Supply Pressures Build

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF)and may include paid advertising. The company has begun its 2026 exploration program at the Murdock Mountain Phosphate Project in northeastern Nevada after completing required wildlife and sage-grouse surveys. The company is preparing additional drill pads to expand understanding of the phosphate zone’s strike extent, thickness, continuity and grade characteristics. Murdock Mountain is a shallow-dipping, road-accessible sedimentary phosphate target zone that could support direct-application organic fertilizer production without chemical processing. Tightening global fertilizer supply, including LPG disruptions linked to instability in the Persian Gulf, may increase interest in phosphate…

WednesdayApr 29, 2026 9:00 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Eyes Growing Gold Market with Prices Projected to Hit $6,000/oz in 2026

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, remains bullish about the 2026 gold prices After an ongoing series of ups-and-downs, by mid-April the price of gold had worked its way past $4,840 per troy ounce to new all-time highs Some analysts have now projected that the price could hit $6,000/oz later in the year, mainly driven by geopolitical issues and continuing economic uncertainty ESGold expects to capitalize on this growth, accelerating development of its flagship Montauban…

TuesdayApr 28, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Deploying AI for Non-Invasive Intoxication Detection

Voice Analytics and AI to Transform Drug and Alcohol Testing Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. MindBio Therapeutics is developing AI-driven voice analysis technology to detect drug and alcohol impairment without relying on invasive and time-consuming breath, saliva, or laboratory testing. The company’s platform analyzes more than 140 acoustic markers and is trained on over 50 million data points to estimate intoxication levels from short voice samples. The new technology is seen applicable to both workplace and non-workplace settings, with the global alcohol and drug testing devices market projected to grow…

TuesdayApr 28, 2026 9:00 am

The Evidence-Interrogation Play: How Oncotelic Therapeutics Inc.’s (OTLC) PDAOAI Platform Fits Pharma’s Broader AI Transformation

Oncotelic's PDAOAI platform indexes 125,000+ PubMed abstracts on TGF-β signaling, enabling researchers to interrogate the evidence for testable, auditable hypotheses rather than rely on black-box predictions. Recent industry coverage places Oncotelic alongside Rockwell Automation, Emerson Electric, Thermo Fisher Scientific, and Danaher as contributors to the pharmaceutical sector's shift toward AI-integrated operations. The hypothesis-first approach addresses a core challenge in biotech research: reducing training-set bias and building transparent, reproducible chains from question to evidence to hypothesis. Pharmaceutical research and manufacturing are undergoing a structural transition. Regulatory agencies are raising expectations around data integrity and traceability, while the industry is shifting from…

MondayApr 27, 2026 9:45 am

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Expands into Orbital Technologies as Space Infrastructure Race Accelerates

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. Planet Ventures is increasing its exposure to AI-driven space infrastructure through strategic investment in Antaris The company is positioning itself at the intersection of orbital computing, satellite software, and the next frontier These moves underscore a broader industry shift toward space-based data infrastructure and lunar-enabling technologies Planet Ventures (CSE: PXI) (OTC: PNXPF) (FSE: P6U) is aligning itself with one of the transformative trends in modern technology: the convergence of space infrastructure and artificial intelligence. With global demand for computing power increasing and terrestrial constraints on…

MondayApr 27, 2026 9:00 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management

The scale and impact of cardiovascular disease underscore why innovation in this area is so critical. Advances in genomics and epigenetics are making it possible to better understand how genetic predisposition and environmental influences interact to drive disease progression. By utilizing a simple blood test, Cardio Diagnostics is lowering barriers to advanced cardiovascular testing. Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on addressing this need by developing advanced solutions that leverage artificial intelligence (“AI”) and…

FridayApr 24, 2026 12:30 pm

Safe Pro Group Inc. (NASDAQ: SPAI) Reveals Its Next-Gen Miniature AI-Powered Edge Compute Processor of Drone Footage for Threat Detection

Safe Pro Group recently began the commercial rollout of NODE-X, a next-gen miniaturized AI-powered edge compute processor of drone footage for threat detection. The rollout began at a U.S. Army Exercise, and NODE-X is scheduled to be a part of additional U.S. Army exercises throughout the second quarter of 2026. NODE-X is powered by Safe Pro’s patented Safe Pro Object Threat Detection (“SPOTD”), a powerful technology used to rapidly analyze drone imagery and video to identify and detect small explosive threats. Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled security, defense, and situational awareness solutions, recently started the commercial…

FridayApr 24, 2026 11:45 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Atikokan Project Assay and Findings Identify Rare Earth Exploration Targets

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Integrated geochemical and geophysical data point to structurally controlled mineralization at Atikokan rare earth property. Dashwa Gneiss Complex emerges as the primary focus for follow-up work. Soil, rock, and sediment sampling indicate consistent rare earth element (“REE”) anomalies. Results support a coherent exploration model rather than isolated occurrences. The project aligns with rising strategic demand for domestic REE supply in North America. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects across North America, has refined its exploration strategy…

FridayApr 24, 2026 11:00 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) AI Platform Brings Precision to Heart Health

At the core of Cardio Diagnostics’ approach is the use of artificial intelligence to integrate multi-omic data to provide a more comprehensive view of cardiovascular health. The company’s proprietary platform is designed to analyze a patient’s molecular profile from a single blood draw and generate actionable insights related to cardiovascular disease risk. CDIO’s focus on accessibility and scalability is also notable. Cardiovascular diagnostics are undergoing a transformation as advances in molecular science and artificial intelligence (“AI”) converge to deliver more precise, individualized insights from minimally invasive tests. Cardio Diagnostics Holdings (NASDAQ: CDIO) is at the forefront of this shift, developing a…

Site Search

Company Search

Category: Articles